Most peptides sold online carry a label stating not for human use. That designation is not a formality, and it matters more than almost anything else about a peptide: in that market, no regulatory system ensures the vial contains what the label claims.
Reviewed by Dr. David Oliak, board-certified surgeon
Updated August 2026
Peptides sold online almost always carry a line of fine print: for research use only, not for human consumption. It is easy to overlook, and it is the most important statement on the label.
"Research use only" is a specific legal category. It means the product was never evaluated or approved for use in people.
It is sold as a raw laboratory material, comparable to a chemical reagent supplied to a lab, and the "not for human use" label is what keeps it outside the regulations that govern medicines.
The designation is the seller stating, in writing, that the product has not been vouched for as safe for human use.
The regulatory gray area matters, but it is not the part that should concern a patient most. Nearly every reputable seller will present third-party laboratory results: a certificate of analysis, purity testing, a description of sourcing. On its face, this appears to be proof.
The difficulty is that nothing independent stands behind it. No regulator audits those certificates, and the results are straightforward to game. A company can test a single clean batch and attach that report to every batch that follows, or represent the figures as it chooses.
The polished website, the certificates, and the confident language are all marketing, and marketing is the one thing an unregulated company can perfect.
What remains is reliance on the honesty of a for-profit company, in a market that competes largely on price, choosing to protect the patient rather than its margin. Some do. In a sector without rules and with real financial pressure, many will not, and nothing prevents it.
When testing is performed by someone other than the seller, the findings tend to be consistent across categories.
Dietary supplements are the familiar example. In a 2023 analysis published in JAMA Network Open, researchers tested 57 sports supplements sold in the United States.
Only 11 percent were accurately labeled, 40 percent contained none of the key labeled ingredient, and 12 percent contained undisclosed FDA-prohibited drugs. These are products sold openly on store shelves, and the labels still could not be relied upon.
Peptides sold as research chemicals face the same gap, with higher stakes, because they are injected. A poorly made oral supplement must at least pass through the gut, which screens and breaks down much of what is swallowed.
An injection removes that barrier: whatever is in the vial, including any bacterial contaminants, enters the body directly.
Published analyses of peptides purchased online have found a significant proportion mislabeled or contaminated, including incorrect or incomplete peptide content, bacterial endotoxins above accepted limits, residual manufacturing solvents, and evidence of non-sterile handling. The specific figures vary by study; the pattern does not.
Many peptides, including some we use, are not FDA-approved medications. Compounding does not change that. What it changes is how the product is made and who is accountable for it.
The peptides we prescribe are prepared by a licensed compounding pharmacy, for human use, against a physician's prescription. That pharmacy holds a license it can lose. It works to established United States Pharmacopeia standards for sterility and quality.
It is accountable to a state board of pharmacy and, through the prescription, to a physician responsible for what the patient receives and how it is used.
The distinction is not that a pharmacy employs better people; it is that a pharmacy operates within a regulatory framework that carries real consequences. A patient's safety does not depend on a company choosing it over profit.
This replaces a promise with a chain of accountability, in which the quality, sterility, and actual contents of the vial are a professional and legal responsibility rather than a claim.
This is the reason we begin with a consultation, and why some peptides require a full evaluation before we will prescribe them. A peptide is only as good as its source and its supervision, and both require a physician's involvement.
When we recommend a peptide, we are accountable for where it came from and for whether it is appropriate for the patient.
Sourcing is only the first half of how we work. The second is that we use peptides as targeted tools. Each is chosen for a defined goal and matched to the patient within a plan we have thought through.
That plan is often on a foundation of the basics first, with the peptide as one considered layer on top. That is the opposite of picking a vial from a menu, and it is why our pages lead to a consultation or a comprehensive evaluation rather than a checkout.
The accountability the online market cannot provide is both the source and the plan.
Even the most reputable-seeming suppliers, those that provide third-party reports and state all the right things, are ultimately asking the buyer to take their word for it. Nothing independent confirms it, and these are for-profit companies with a strong incentive to present favorably.
Before we prescribe a peptide for a patient, we require more than a seller's assurance. We require an accountable, regulated source.
— Dr. David Oliak, board-certified physician and surgeon
When there is no regulation, how trustworthy a company appears is a marketing outcome, not a verified fact, and these companies market well. Appearing trustworthy and being verifiable are not the same, and the difference is precisely where a patient's safety would rest.
We are not willing to place a patient's health on that difference when a regulated, accountable alternative exists.
— Dr. David Oliak, board-certified physician and surgeon
Let's begin
Peptides are most appropriate as part of a plan prescribed and supervised by a physician who stands behind the source. Start with a comprehensive evaluation, or schedule a focused peptide consultation.
Wolverine (BPC-157 / TB-500)
GHK-Cu and GLOW for skin, hair, and repair
Growth hormone peptides: Tesamorelin and Sermorelin
What a comprehensive evaluation includes
There is no reliable way to know, which is the central problem. Sellers present third-party lab reports, but no regulator audits them and they are straightforward to game, so the buyer is relying on an unregulated for-profit company to police itself.
Independent testing of online peptides regularly finds mislabeling and contamination. Peptides prescribed and compounded for human use are instead held to pharmacy quality and sterility standards by an accountable, licensed pharmacy.
Most peptides used in wellness are not FDA-approved as finished drugs. That is precisely why how they are obtained matters. A peptide compounded for human use through a licensed pharmacy, on a physician's prescription, is a fundamentally different product from a research chemical purchased online, even when the molecule is the same.
Research-only peptides are sold as laboratory chemicals, labeled not for human use, with no regulator standing behind the seller's own test reports. Compounded peptides are prepared by a licensed pharmacy for human use against a prescription, to established quality and sterility standards, with a pharmacy and physician accountable for them.
You can, but that means purchasing an unverified product with no one accountable for its contents. Given how frequently these products test as mislabeled or contaminated, and that they are injected, we do not consider it worth the risk. Our role is to prescribe a properly sourced peptide and supervise its use.
